BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leavitt C, Zakai NA, Auer P, Cushman M, Lange EM, Levitan EB, Olson N, Thornton TA, Tracy RP, Wilson JG, Lange LA, Reiner AP, Raffield LM. Interferon gamma-induced protein 10 (IP-10) and cardiovascular disease in African Americans. PLoS One 2020;15:e0231013. [PMID: 32240245 DOI: 10.1371/journal.pone.0231013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wahyuni T, Tanaka S, Igarashi R, Miyake Y, Yamamoto A, Mori S, Kametani Y, Tomimatsu M, Suzuki S, Yokota K, Okada Y, Maeda M, Obana M, Fujio Y. CXCL10 is a novel anti-angiogenic factor downstream of p53 in cardiomyocytes. Physiol Rep 2022;10:e15304. [PMID: 35542987 DOI: 10.14814/phy2.15304] [Reference Citation Analysis]
2 Barros B, Oliveira M, Morais S. Firefighters' occupational exposure: Contribution from biomarkers of effect to assess health risks. Environ Int 2021;156:106704. [PMID: 34161906 DOI: 10.1016/j.envint.2021.106704] [Reference Citation Analysis]
3 Olson NC, Raffield LM, Moxley AH, Miller-Fleming TW, Auer PL, Franceschini N, Ngo D, Thornton TA, Lange EM, Li Y, Nickerson DA, Zakai NA, Gerszten RE, Cox NJ, Correa A, Mohlke KL, Reiner AP. Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Blacks. Circ Genom Precis Med 2021;:CIRCGEN121003421. [PMID: 34706549 DOI: 10.1161/CIRCGEN.121.003421] [Reference Citation Analysis]